Tuan Vu on Muck Rack

Tuan Vu

Da Nang
As seen in: Wiley Online Library, Journal of Retailing and Consumer Services, MDPI, ACS Publications, The New England Journal of Medicine, HackerNoon, The Lancet, Canadian Journal of Infectious Diseases & Medical Microbiology, DEV Community, University of Wollongong and

Get in touch with Tuan

Contact Tuan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Tuan Vu’s Biography

Read Full Bio →

TOP 7 THINGS TO DO IN HOI AN
Whether traveling alone or with family, tourists have countless things to do in Hoi An Ancient Town, which used to be a prosperous commercial port of Southeast Asia. From a boat trip to lantern release on the Hoai River to Bai Choi games or quick tailoring, all are unforgettable experiences when visiting this tranquil city.
Truth be told, to feel the true rhythm of life here, one or two days might not be enough; however, if you are in a rushing visit, here are 7 mus…

Articles

Nimble Nomads Forex Sniper

|
By Tuan Vu
| mql5.com
GatesFX:https://secure.gatesfx.com/links/go/2514 OPEN LIVE ACCOUNT MT5 | 1:500 Leverage My strategy : CUT LOSSES, KEEP YOUR MONEY SAFE, AND GROWING. I will be trading using Price Action, Bank Logic, and Smart Money Concepts. When you trade like the banks, you will always make money in the long run. Safety first: I DO NOT use grid, martingale, averaging down or any other risky trade management methods.
Open in Who Shared Issue with article?

Video: Cemdisiran Monotherapy in Myasthenia Gravis—AAN 2026 Expert Insights

|
By Tuan Vu, Casey Nevins
| Neurology Advisor Verified
Interview Transcript Hi, my name is Tuan Vu. I’m a Professor of Neurology at the University of South Florida Morsani College of Medicine. Neurology Advisor: “What was the primary objective of the NIMBLE trial (ClinicalTrials.gov Identifier: NCT05070858)?” Dr Vu: When the study was designed back in 2019 or so, we only had 1 C5 inhibitor on the market.
Open in Who Shared Issue with article?

Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial

|
By Tuan Vu, Ali A Habib, Saiju Jacob
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Gilhus, NE ∙ Tzartos, S ∙ Evoli, A ∙ et al. Myasthenia gravis Nat Rev Dis Primers. 2019; 5:30 2. Hehir, MK ∙ Silvestri, NJ Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology Neurol Clin. 2018; 36:253-260 3. Claytor, B ∙ Cho, S-M ∙ Li, Y Myasthenic crisis Muscle Nerve. 2023; 68:8-19 4. San, PP ∙ Jacob, S Role of complement in myasthenia gravis Front Neurol.
Open in Who Shared Issue with article?
See all 46 licensed articles (83 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified